Cannabinoid system in the skin - A possible target for future therapies in dermatology

73Citations
Citations of this article
145Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

Cannabinoids and their derivatives are group of more than 60 biologically active chemical agents, which have been used in natural medicine for centuries. The major agent of exogenous cannabinoids is Δ9-tetrahydrocannabinol (Δ9-THC), natural psychoactive ingredient of marijuana. However, psychoactive properties of these substances limited their use as approved medicines. Recent discoveries of endogenous cannabinoids (e.g. arachidonoylethanolamide, 2-arachidonoylglycerol or palmithyloethanolamide) and their receptors initiated discussion on the role of cannabinoid system in physiological conditions as well as in various diseases. Based on the current knowledge, it could be stated that cannabinoids are important mediators in the skin, however their role have not been well elucidated yet. In our review, we summarized the current knowledge about the significant role of the cannabinoid system in the cutaneous physiology and pathology, pointing out possible future therapeutic targets. © 2009 John Wiley & Sons A/S.

Cite

CITATION STYLE

APA

Kupczyk, P., Reich, A., & Szepietowski, J. C. (2009, August). Cannabinoid system in the skin - A possible target for future therapies in dermatology. Experimental Dermatology. https://doi.org/10.1111/j.1600-0625.2009.00923.x

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free